MO

Business Context and Reporting Period

This Form 10-Q is a quarterly report for Philip Morris Companies Inc. (Note: The input metadata lists "Altria Group, Inc.", but the filing text explicitly identifies the registrant as Philip Morris Companies Inc.) for the period ended September 30, 1999. The company operates in two primary segments: Consumer Products (Domestic Tobacco, International Tobacco, North American Food, International Food, and Beer) and Financial Services.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenues increased 5.8% ($3.2 billion) year-over-year, driven primarily by domestic tobacco pricing increases.
• Profitability: Net earnings rose 14.1% ($720 million). Diluted EPS increased 15.3% to $2.41.
• Settlement Charges: The 1999 period included $1,116 million in settlement charges related to tobacco litigation (compared to $1,116 million in 1998, though the 1998 figure was a one-time settlement charge while 1999 reflects ongoing obligations and specific charges). Specifically, 1999 operating income included pre-tax charges of $183 million for domestic tobacco separation programs, $157 million for North American food workforce reductions, and $136 million for an international tobacco factory closure in Brazil.
• Cash Flow: Net cash provided by operating activities increased significantly to $9.2 billion, largely due to the timing of collecting settlement-related revenues prior to remittance to state governments.
• Share Repurchases: The company repurchased 56.6 million shares for $2.2 billion in the first nine months of 1999, resuming a program that was inactive in the comparable 1998 period.

Guidance, Outlook, and Risks

• Year 2000 (Y2K) Readiness: The company estimates total Y2K readiness costs at approximately $550 million, with $500 million already spent. Preemptive contingency plans (stockpiling, etc.) are estimated to cost an additional $75 million. Management anticipates some localized disruptions but believes they will not have a material adverse effect on consolidated results.
• Litigation Risks: Significant uncertainty remains regarding tobacco-related litigation. Key risks include the Engle class action trial in Florida (Phase One verdict against defendants), a new federal lawsuit by the U.S. government seeking over $20 billion annually in health care costs, and ongoing health care cost recovery actions globally. Management states it is unable to estimate the potential loss range.
• Regulatory Environment: Risks include potential FDA regulation of cigarettes as "drugs" (pending Supreme Court review), proposed federal excise tax increases, and ingredient disclosure laws.
• Currency Impact: A strong U.S. dollar against the euro and other currencies negatively impacted operating revenues by $159 million and operating income by $48 million in the first nine months of 1999.
• Dividends: The quarterly dividend was increased by 9.1% to $0.48 per share in August 1999.

Investor Verification Checklist

• Verify the status and potential financial impact of the Engle class action trial in Florida, specifically regarding the Phase Two punitive damages determination.
• Monitor the outcome of the U.S. Supreme Court review regarding FDA jurisdiction over tobacco products.
• Assess the impact of the Master Settlement Agreement (MSA) on future cash flows, noting the required annual payments starting at $4.2 billion in 1999 and rising to $9.2 billion in 2000.
• Review the company's Y2K contingency plans and the actual occurrence of disruptions in international markets (Eastern Europe, Latin America) as the year 2000 approaches.
• Track domestic tobacco shipment volumes and market share, which declined 9.9% year-over-year, to gauge the effectiveness of recent price increases.